Dimension Therapeutics Receives Positive Opinion for European Orphan Drug Designation for DTX301 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency CAMBRIDGE, Mass., March 17, 2016 (GLOBE NEWSWIRE) — Dimension Therapeutics, Inc. (NASDAQ:DMTX), a...
Versartis Announces Two Abstracts from Ongoing Pediatric Extension Study of Somavaratan Selected for Late-Breaker Presentations at the Endocrine Society’s 98th Annual Meeting MENLO PARK, Calif., March 14, 2016 (GLOBE NEWSWIRE) — Versartis, Inc....
Arvinas Appoints Angela Shen as Chief Medical Officer NEW HAVEN, CT, March 2, 2016 – Arvinas LLC, a biotechnology company creating a new class of oncology drugs based on protein degradation, announced the appointment of Angela Shen, M.D., M.B.A, as chief medical...
Summa Health Selects ProviderMatch to Power Access for Clinically Integrated Network Leading health system will leverage Kyruus’ suite of solutions to optimize physician care coordination across Ohio’s largest CIN Boston, MA, March 1, 2016 – Kyruus, Inc., a leading...
Recent Comments